brca pancreatic cancer maintenance debate: parp inhibitor or continued chemo? - parp inhibitor
Published 3 years ago • 462 plays • Length 10:42Download video MP4
Download video MP3
Similar videos
-
7:30
brca pancreatic cancer maintenance debate: parp inhibitor or continued chemo? - cont'd chemotherapy
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
2:59
parp inhibitor olaparib as treatment for pancreatic cancer patients with brca gene mutations
-
11:49
brca & parp inhibitors: targeted chemotherapy | #markscholzmd #alexscholz @pcri
-
28:39
new treatment options in pancreatic cancer
-
23:48
improving the outcome of patients with metastatic pancreatic cancer
-
8:19
maintenance therapy with parp inhibitor olaparib delays progression of brca-related pancreatic c...
-
31:54
pancreatic cancer breakout: new potential in pancreatic cancer
-
31:27
what's new for pancreatic cancer treatment?
-
17:46
pancreas cancers absite and board review
-
1:32
parp inhibitor olaparib exceeds expectations in brca pancreatic cancer management
-
0:59
dr. simeone on impact of parp inhibitors on pancreatic cancer
-
4:47
maintenance therapy with parp inhibitor olaparib delays progression in patients with brca-relate...
-
3:12
parp-inhibitors: a new generation of cancer drugs
-
2:19
phase iii results of olaparib for brca breast cancer
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
0:54
parp inhibitors advance beyond treatment of brca1/2-mutant gynecologic cancers
-
3:45
parp inhibitors gbrca1/2-mutated pancreatic cancer
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer